Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified

Total article views   HTML views PDF downloads Totals
6,040 Dovepress* 5,095+ 1,274 6,369
PubMed Central* 945 395 1,340
Totals 6,040 1,669 7,709
*Since 13 November 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar